Related Experiment Video
Updated: Apr 6, 2026

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
Plasma Exchange Therapy in Patients with Complex Regional Pain Syndrome
Enrique Aradillas, Robert J Schwartzman, John R Grothusen
1Drexel University College of Medicine, Philadelphia, PA.
Plasma exchange therapy (PE) effectively reduced pain in most complex regional pain syndrome (CRPS) patients with small fiber neuropathy. Pain reduction was maintained with ongoing PE or other immune therapies, suggesting PE as a viable treatment option for severe CRPS.
Area of Science:
- Neurology
- Immunology
- Pain Medicine
Background:
- Complex regional pain syndrome (CRPS) is a severe chronic pain condition often following trauma, potentially linked to small-diameter peripheral axon degeneration.
- Intravenous immunoglobulin (IVIG) shows efficacy in painful polyneuropathies, and some CRPS patients have responded to it.
- A hypothesis of autoimmune etiology in CRPS prompted the investigation of plasma exchange therapy (PE) for patients with small fiber neuropathy.
Purpose of the Study:
- To evaluate the efficacy of plasma exchange therapy (PE) in CRPS patients with small fiber neuropathy.
- To assess PE's effectiveness in patients unresponsive or poorly responsive to existing treatments.
Main Methods:
- A retrospective case series of 33 CRPS patients meeting Budapest criteria who received PE between September 2012 and June 2014.
- Patients underwent comprehensive evaluations including pain assessment, the McGill questionnaire, quantitative sensory testing (QST), and skin punch biopsy.
- The PE protocol involved 5-11 sessions over 2-3 weeks, followed by pain evaluation and consideration of maintenance therapy (weekly PE, oral immune modulators, or IVIG).
Main Results:
- Thirty of 33 patients experienced a significant median pain reduction of 64% after the initial PE series (P < 0.01).
- Twenty-four patients maintained pain reduction with maintenance therapy (weekly PE, oral immune modulators, or IVIG).
- Patients with greater small fiber loss and temperature sensory deficits showed the most benefit from PE.
Conclusions:
- Plasma exchange therapy (PE) is effective for a subset of severe, long-standing CRPS patients with small fiber neuropathy.
- Initial pain reduction from PE can be sustained with maintenance therapy, including weekly PE, IVIG, or other immune-modulating drugs.
- Further large, randomized, placebo-controlled studies are needed to confirm these findings and explore new therapies for CRPS.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Continuous Renal Replacement Therapy
Peripheral Artery Disease III: Interprofessional Care
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...

